Structure-activity relationship of peptide fragments derived from DBI (diazepam binding inhibitor), a putative endogenous ligand of benzodiazepine recognition sites.
D000374:Aggression / Q000187:drug effects; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D026261:Diazepam Binding Inhibitor; D008970:Molecular Weight; D009479:Neuropeptides / Q000378:metabolism* / Q000494:pharmacology; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D011963:Receptors, GABA-A / Q000378:metabolism*; D013329:Structure-Activity Relationship
D026261:Diazepam Binding Inhibitor; D009479:Neuropeptides; D010446:Peptide Fragments; D011963:Receptors, GABA-A